Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1401–1450 of 34667
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").
On April 22, 2026, James Nevels resigned as a director of Roman DBDR Acquisition Corp. II (the “Company”), effective immediately.
On April 27, 2026, the Company’s Board of Directors (the “Board”) appointed Randolph C. Read to serve as a member of the Board, effective immediately.
In connection with the consummation of the Merger, Wade Sherman was appointed to the board of directors of the Company, effective as of the Effective Time.
her decision to resign as a director of TYG, effective as of July 1, 2026.
On April 27, 2026, the Board of Directors (the “Board”) of Andersen Group Inc. (the “Company”) appointed Susan Decker as a member of the Board, with her initial term expiring at the Company’s 2026 annual meeting of stockholders.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
The directors of Purchaser immediately prior to the Effective Time were David Ferrick, Peter Necheles and Jeffrey Blecher.
The directors of Purchaser immediately prior to the Effective Time were David Ferrick, Peter Necheles and Jeffrey Blecher.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
at the Effective Time, each of Mathew Booth, Gina Domanig, Suzie Doran, James M. Micali, Ryan Pollock and Alexandre Zyngier resigned from the board of directors of the Company.
The directors of Purchaser immediately prior to the Effective Time were David Ferrick, Peter Necheles and Jeffrey Blecher.
Shane Grant, a member of the Board, informed the Board that he plans to retire from the Board at the end of his current term and will not stand for reelection at the Annual Meeting.
On April 26, 2026, the board of directors (the "Board") of lululemon athletica inc. (the "Company") appointed Esi Eggleston Bracey as a member of the Board, effective April 28, 2026.
On April 24, 2026, the Board of Directors (the “Board”) of Lakewood-Amedex Biotherapeutics Inc. (the “Company”) appointed Dr. Joseph Tucker to fill a vacancy and serve as a member of the Board, effective April 24, 2026.
On April 22, 2026, our shareholders approved at an Extraordinary General Meeting the appointment of David Natan and Avraham Ben-Tzvi to our board of directors, and Mr. Natan and Mr. Ben-Tzvi became directors of our company.
On April 22, 2026, our shareholders approved at an Extraordinary General Meeting the appointment of David Natan and Avraham Ben-Tzvi to our board of directors, and Mr. Natan and Mr. Ben-Tzvi became directors of our company.
On April 25, 2026, the term of Gregory Shayne Bench as a member of the Board of Directors (the “Board”) of SafeSpace Global Corporation expired pursuant to the Company’s corporate governance guidelines, which provide for mandatory term limits for directors.
On April 25, 2026, Andrzej Olechowski, a member of the Board of Directors (the "Board") of Euronet Worldwide, Inc. (the "Company"), passed away.
On June 24, 2025, Farmers & Merchants Bancorp, Inc. (the “Company”) named Ahmed Alomari as a member of the Company’s and the Company’s wholly-owned bank subsidiary, The Farmers & Merchants State Bank (the “Bank”) Boards of Directors effective July 29, 2025.
On June 25, 2025, the Board of Directors (the “Board”) of Dominion Energy, Inc. (“Dominion Energy” or the “Company”) elected Mr. Jeffrey J. Lyash to the Board as an independent director, effective June 25, 2025.
On June 23, 2025, the Board appointed a new independent director, Garth Lees-Rolfe, to hold office until the earlier of the expiration of the term of office, a successor is duly elected and qualified, or the earlier of her death, resignation, disqualification, or removal.
On June 24, 2025, Michele Morrow resigned from her position as a member of the board of directors of Brag House Holdings, Inc. (the “ Company ”), effective immediately.
On June 20, 2025, the Board of Directors (the “Board”) of ProPhase Labs, Inc. (the “Company”) appointed Carolina Abenante, Esq. to serve as an independent director to fill the existing vacancy on the Board.
appointed Eric Boehnke and Youngsun Park, a/k/a Sunny Park, to the Board as nominees of the Purchaser
appointed Eric Boehnke and Youngsun Park, a/k/a Sunny Park, to the Board as nominees of the Purchaser
On June 19, 2025, Mr. John Mazarakis notified the Board of Directors (the “Board”) of Chicago Atlantic BDC, Inc. (the “Company”) of his resignation, effective as of June 20, 2025, from his position as an interested Director on the Company's Board.
On June 23, 2025, the Board of Directors (the “Board”) of SmartRent, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Nominating Committee”), appointed Thomas Bohjalian to the Board as a Class I director to serve until the Company’s 2028 annual meeting of stockholders.
On June 22, 2025, Elinor Mertz was appointed to the Board of Directors (the "Board") of Netflix, Inc. (the "Company") effective immediately
On June 19, 2025, the Board of Directors of NeoGenomics, Inc. (the "Company") increased the size of the Board of Directors (the "Board") from nine to ten members and appointed Marjorie C. Green as a director to fill the vacancy resulting from that increase.
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.
the Board appointed Mr. Sjolund as a director, effective immediately
appointed the Company’s CEO Stephen Silvestro to serve as a director
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
on June 17, 2025, the Board appointed Bjarne Borg, James D. Burnham and Anthony M. Cialone, each of whom was designated by a majority in interest of the former members of Resource Group, as directors of the Company, in Classes I, III and II, respectively.
on June 17, 2025, the Board appointed Bjarne Borg, James D. Burnham and Anthony M. Cialone, each of whom was designated by a majority in interest of the former members of Resource Group, as directors of the Company, in Classes I, III and II, respectively.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.